Ellevest Inc’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,935
Closed -$50.1K 1476
2023
Q1
$50.1K Buy
1,935
+648
+50% +$17.3K ﹤0.01% 602
2022
Q4
$30.4K Buy
1,287
+147
+13% +$3.96K ﹤0.01% 738
2022
Q3
$29K Sell
1,140
-297
-21% -$10.4K ﹤0.01% 725
2022
Q2
$48K Buy
1,437
+567
+65% +$24.1K ﹤0.01% 576
2022
Q1
$63K Buy
870
+425
+96% +$30.6K 0.01% 483
2021
Q4
$41K Buy
445
+254
+133% +$30.4K ﹤0.01% 561
2021
Q3
$24K Buy
+191
New +$27.8K ﹤0.01% 632
2021
Q2
Sell
-156
Closed -$28K 1417
2021
Q1
$28K Sell
156
-195
-56% -$45.2K ﹤0.01% 596
2020
Q4
$70K Buy
351
+319
+997% +$64.9K 0.01% 388
2020
Q3
$7K Buy
32
+26
+433% +$5.51K ﹤0.01% 720
2020
Q2
$1K Buy
+6
New +$1.05K ﹤0.01% 1057

Other funds holding TDOC

Ellevest Inc's TDOC Position: Q2 2023 in Review

Ellevest Inc sold out of Teladoc Health (TDOC) in Q2 2023, closing a stake of 1,935 shares — an estimated $50.1K sold.

Ellevest Inc first reported a position in TDOC in Q2 2020 and held it in 11 quarters. The position peaked at $70K in Q4 2020. 431 funds tracked by Wall St. Rank hold TDOC as of Q2 2023.

  • Ellevest Inc reported no remaining Teladoc Health position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 1,935 Teladoc Health shares in Q2 2023, an estimated $50.1K.
  • Ellevest Inc first reported a position in Teladoc Health in Q2 2020 and held it in 11 quarters.
  • Ellevest Inc's Teladoc Health position peaked at $70K in Q4 2020.
  • 431 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.